Synthesis of vildagliptin conjugated metal nanoparticles for type II diabetes control: targeting the DPP-IV enzyme
Sign Up to like & getrecommendations! Published in 2020 at "New Journal of Chemistry"
DOI: 10.1039/d0nj04202a
Abstract: Diabetes is one of the most prevalent diseases worldwide. Vildagliptin is a drug which overcomes the existing problems of anti-diabetic drugs. However, the short half-life (2–3 h) of vildagliptin remains an important concern. Recently there… read more here.
Keywords: synthesis vildagliptin; metal nanoparticles; vildagliptin; drug ... See more keywords